Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curis Inc (NQ: CRIS )

0.5960 +0.0462 (+8.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 358,417
Open 0.5500
Bid (Size) 0.5810 (1)
Ask (Size) 0.6000 (24)
Prev. Close 0.5498
Today's Range 0.5500 - 0.5960
52wk Range 0.4700 - 2.510
Shares Outstanding 91,596,369
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curis's Return On Capital Employed Overview
 
Via Benzinga
A Preview Of Curis's Earnings
 
Via Benzinga

Performance

YTD
-3.26%
-3.26%
1 Month
-5.40%
-5.40%
3 Month
+8.36%
+8.36%
6 Month
-14.86%
-14.86%
1 Year
-74.96%
-74.96%

More News

Read More
Earnings Preview For Curis
Via Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Looking Into Curis's Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Is Curis (CRIS) Stock Up 20% Today?
Via InvestorPlace
FDA Clears Curis' Lymphoma Study, Keeping Leukemia Trial Still Stalled
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Earnings Outlook For Curis
Via Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Curis Resumes Enrollment In Monotherapy TakeAim Leukemia Study, Combo Phase Still Under Partial Hold
Via Benzinga
Curis's Return On Capital Employed Insights
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Analyzing Curis Short Interest
Via Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Dow Falls 60 Points; Crude Oil Rises Sharply
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
BLUE Stock Moves as FDA Approves Bluebird Bio’s Gene Therapy
Via InvestorPlace
U.S. Stocks Turn Higher; Nasdaq Rises 50 Points
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
6 Penny Stocks With 1,000% Upside Potential
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.